| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445252 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
Patients on MTA in Phase I clinical trials had a preserved mental and physical activity whereas their sexual activity declined in both sexes. The impact of MTA on HRQoL and especially sexual function should be routinely assessed in further studies to better understand their potential impact in advanced cancer patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mathieu Rouanne, Christophe Massard, Antoine Hollebecque, Vanessa Rousseau, Andrea Varga, Anas Gazzah, Yann Neuzillet, Thierry Lebret, Jean-Charles Soria,